Sight Sciences, Inc. (SGHT) Stock

Sight Sciences, Inc. (SGHT) is a Healthcare stock trading at $5.27 (as of 2026-06-18), with a market capitalization of $264.43M and a trailing P/E of -6.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Sight Sciences, Inc. develops and commercializes ophthalmic technologies for surgical and nonsurgical treatment of eye diseases. Its offerings include the OMNI Surgical System for adult glaucoma therapy and the TearCare System for dry eye disease, which are sold through representatives and distributors to hospitals and eyecare professionals in the United States.

Valuation — source: SEC EDGAR (first-party)
Price	$5.27
Market Cap	$264.43M
P/E Ratio	-6.9
EV / EBITDA	-6.2
Price / Book	4.91
Price / Sales	3.32
DCF Value (model)	$-8.47
DCF Upside vs Price	-260.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$77.36M
Net Margin	-49.7%
Return on Equity	-69.1%
Debt / Equity	0.75
Current Ratio	5.86
Revenue Growth (YoY)	12.5%
EPS Growth (YoY)	-14.3%
FCF Growth (YoY)	-38.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	-0.68 (distress)
Piotroski F-Score	5/9 (moderate)

Valuation vs Sector & Industry
Stock P/E	-6.9
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-133.1%
vs Industry	-121.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($15.45M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Paul Badawi
Employees	216
Country	US
IPO Date	2021-07-15

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.